Clinical Trial Update: A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication [Phase 4]

View source ↗

Summary

Phase 4 study comparing risperidone long-acting injectable with oral antipsychotics in people with schizophrenia who had poor medication adherence was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Risperdal (risperidone)
• Risperdal Consta (risperidone long-acting injectable)

Snippet

Sponsor: Janssen-Ortho Inc., Canada | Conditions: Schizophrenia | Phase 4 | Status: TERMINATED | Results posted: 2013-10-07